Market Overview:
The global molecular diagnostics in infectious disease testing market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The market growth is attributed to the increasing incidence of infectious diseases, technological advancements in molecular diagnostics, and growing demand for point-of-care (POC) tests. Based on type, the global molecular diagnostics in infectious disease testing market is segmented into polymerase chain reaction (PCR), isothermal nucleic acid amplification technology (INAAT), microarrays, next-generation sequencing (NGS), hybridization, and others. PCR held the largest share of the global molecular diagnostics in infectious disease testing market in 2017 owing to its high accuracy and sensitivity. Based on application, hospitals accounted for the largest share of the global molecular diagnostics in infectious disease testing market in 2017 followed by clinics and academic institutes. The large share of this segment can be attributed to rising demand for diagnostic tests from hospitals across the globe coupled with increasing number of patients suffering from various types of infections.
Product Definition:
Molecular diagnostics is a laboratory testing method that uses molecular biology techniques to identify and characterize microorganisms. This type of testing is important for infectious disease diagnosis, because it can detect the presence of a virus or bacteria at the DNA or RNA level. This allows for more accurate identification and susceptibility testing, which can help guide treatment decisions.
Polymerase Chain Reaction (PCR):
PCR is a technique that involves the amplification of specific DNA sequences from a DNA sample. The process is widely used in molecular biology for the diagnosis of infectious diseases, genetic disorders, and other medical conditions. PCR is also known as quantitative PCR (qPCR) or real-time PCR (RT-PCR). It works by using two enzymes; Polymerase Chain Reaction (PCR) and reverse transcriptase enzyme to copy & amplify the targeted gene sequence from a RNA or DNA sample.
Isothermal Nucleic Acid Amplification Technology (INAAT):
INAAT is an innovative molecular diagnostic technology that amplifies the DNA or RNA of a specific gene to make millions of copies of the targeted sequence. The process does not require any heat, unlike most PCR (polymerase chain reaction) based tests. It also allows rapid amplification and provides highly accurate results in a short time.
INAAT was developed by researchers at MIT.
Application Insights:
The hospitals segment dominated the global molecular diagnostics in infectious disease testing market and accounted for more than a 38% share of the overall revenue in 2017. This is attributed to factors such as high volume of tests performed, presence of key players with superior technology, and an extensive network across the globe.
Moreover, this segment is expected to maintain its dominance over the forecast period owing to factors such as increasing investments by major players for R&D activities related to molecular diagnostic tests. For instance, in March 2016 Illumina collaborated with Myriad Genetics on a research agreement that involved analysis of genetic data from 1 million patients suffering from rare diseases.
Regional Analysis:
North America dominated the global molecular diagnostics in infectious disease testing market with a revenue share of over 38% in 2017. This is due to the presence of well-established healthcare infrastructure, high adoption rate for advanced diagnostic technologies, and government funding for R&D activities related to infectious diseases. For instance, according to an article published by NCBI in 2018 titled “Epidemiological transition and its impact on control strategies: Implications for control programs targeting mosquito-borne illnessesâ€, between 2000 and 2016 there was a decline from around 50% of people getting tested for these diseases to less than 10%. However this has now increased with more people being tested which will lead towards better outcomes as well as higher treatment efficacy rates.
Growth Factors:
- Increasing incidence of infectious diseases: The global incidence of infectious diseases is increasing at a rapid pace. This is primarily due to the changing lifestyles and environmental conditions. Molecular diagnostics offers an accurate and rapid diagnosis of these infections, which helps in early treatment and prevention of their spread.
- Growing demand for personalized medicine: Molecular diagnostics allows for the customization of medical treatments according to the individual’s genetic makeup. This helps in achieving better patient outcomes and reducing the side effects associated with traditional therapies.
- Technological advancements: The field of molecular diagnostics is constantly evolving, with new technologies being developed on a regular basis. These technologies offer improved accuracy, speed, and cost-efficiency compared to traditional diagnostic methods.
Scope Of The Report
Report Attributes
Report Details
Report Title
Molecular Diagnostics in Infectious Disease Testing Market Research Report
By Type
Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), Microarrays, Next-Generation Sequencing (NGS), Hybridization, Others
By Application
Hospitals, Clinics, Academic Institutes, Laboratories, Others
By Companies
Abbott, BD, BioMerieux, Thermo Fisher Scientific, Roche, Siemens, Veridex, Luminex, GenMark Diagnostics, Qiagen, Genomix Biotech, BioTheranostics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
180
Number of Tables & Figures
126
Customization Available
Yes, the report can be customized as per your need.
Global Molecular Diagnostics in Infectious Disease Testing Market Report Segments:
The global Molecular Diagnostics in Infectious Disease Testing market is segmented on the basis of:
Types
Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), Microarrays, Next-Generation Sequencing (NGS), Hybridization, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Academic Institutes, Laboratories, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- BD
- BioMerieux
- Thermo Fisher Scientific
- Roche
- Siemens
- Veridex
- Luminex
- GenMark Diagnostics
- Qiagen
- Genomix Biotech
- BioTheranostics
Highlights of The Molecular Diagnostics in Infectious Disease Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Polymerase Chain Reaction (PCR)
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Microarrays
- Next-Generation Sequencing (NGS)
- Hybridization
- Others
- By Application:
- Hospitals
- Clinics
- Academic Institutes
- Laboratories
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Molecular Diagnostics in Infectious Disease Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Molecular diagnostics is a type of testing that uses DNA or RNA to identify the cause of an illness. This type of testing can be used to diagnose infections, cancer, and other diseases. Molecular diagnostics can also be used to monitor the health of people who are sick.
Some of the major companies in the molecular diagnostics in infectious disease testing market are Abbott, BD, BioMerieux, Thermo Fisher Scientific, Roche, Siemens, Veridex, Luminex, GenMark Diagnostics, Qiagen, Genomix Biotech, BioTheranostics.
The molecular diagnostics in infectious disease testing market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Molecular Diagnostics in Infectious Disease Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Molecular Diagnostics in Infectious Disease Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Molecular Diagnostics in Infectious Disease Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Molecular Diagnostics in Infectious Disease Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Molecular Diagnostics in Infectious Disease Testing Market Size & Forecast, 2020-2028
4.5.1 Molecular Diagnostics in Infectious Disease Testing Market Size and Y-o-Y Growth
4.5.2 Molecular Diagnostics in Infectious Disease Testing Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Polymerase Chain Reaction (PCR)
5.2.2 Isothermal Nucleic Acid Amplification Technology (INAAT)
5.2.3 Microarrays
5.2.4 Next-Generation Sequencing (NGS)
5.2.5 Hybridization
5.2.6 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Academic Institutes
6.2.4 Laboratories
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Molecular Diagnostics in Infectious Disease Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Molecular Diagnostics in Infectious Disease Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Polymerase Chain Reaction (PCR)
9.6.2 Isothermal Nucleic Acid Amplification Technology (INAAT)
9.6.3 Microarrays
9.6.4 Next-Generation Sequencing (NGS)
9.6.5 Hybridization
9.6.6 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Academic Institutes
9.10.4 Laboratories
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Polymerase Chain Reaction (PCR)
10.6.2 Isothermal Nucleic Acid Amplification Technology (INAAT)
10.6.3 Microarrays
10.6.4 Next-Generation Sequencing (NGS)
10.6.5 Hybridization
10.6.6 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Academic Institutes
10.10.4 Laboratories
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Polymerase Chain Reaction (PCR)
11.6.2 Isothermal Nucleic Acid Amplification Technology (INAAT)
11.6.3 Microarrays
11.6.4 Next-Generation Sequencing (NGS)
11.6.5 Hybridization
11.6.6 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Academic Institutes
11.10.4 Laboratories
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Polymerase Chain Reaction (PCR)
12.6.2 Isothermal Nucleic Acid Amplification Technology (INAAT)
12.6.3 Microarrays
12.6.4 Next-Generation Sequencing (NGS)
12.6.5 Hybridization
12.6.6 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Academic Institutes
12.10.4 Laboratories
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Polymerase Chain Reaction (PCR)
13.6.2 Isothermal Nucleic Acid Amplification Technology (INAAT)
13.6.3 Microarrays
13.6.4 Next-Generation Sequencing (NGS)
13.6.5 Hybridization
13.6.6 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Academic Institutes
13.10.4 Laboratories
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Molecular Diagnostics in Infectious Disease Testing Market: Competitive Dashboard
14.2 Global Molecular Diagnostics in Infectious Disease Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott
14.3.2 BD
14.3.3 BioMerieux
14.3.4 Thermo Fisher Scientific
14.3.5 Roche
14.3.6 Siemens
14.3.7 Veridex
14.3.8 Luminex
14.3.9 GenMark Diagnostics
14.3.10 Qiagen
14.3.11 Genomix Biotech
14.3.12 BioTheranostics
